PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: PlacidWay

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

PlacidWay Furthers Relationship with Panama-Based Stem Cell Facility - PlacidWay continues their relationship with Stem Cell Panama, focusing on stem cell and regenerative medicine in Panama City, Panama - PlacidWay.com
PlacidWay Furthers Relationship with Panama-Based Stem Cell Facility

 

NewswireToday - /newswire/ - Castle Pines, CO, United States, 2013/05/07 - PlacidWay continues their relationship with Stem Cell Panama, focusing on stem cell and regenerative medicine in Panama City, Panama - PlacidWay.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

PlacidWay continues to develop relations with Stem Cell and Regenerative Medicine Panama, a facility located in Panama City, Panama. The facility focuses on regenerative medicine through the use of stem cells, and also provides treatments for Parkinson's disease, diabetes, arthrosis, joints pain, rheumatism, multiple sclerosis, autism and other metabolic conditions.

The Panama-based stem cell facility focuses on applied research when it comes to regenerative medicine specializing in stem cell therapies. The latest advances in stem cell technologies enable Stem Cell Panama to focus on treatments that restore function and repair structures in damaged cellular tissues as well as organs. “Due to the aging process, renewable and repairable tissues grow increasingly limited with age, and therefore, regenerative medicine and its therapies focus on restoration of such tissues and organs in the body as we age,” states Dr. Esteban Estrada, scientific adviser with Stem Cell Panama. "Stem cell Panama focuses stem cell therapies to treat cardiovascular, osteo- articular and rheumatology disease processes.”

"Neurological diseases such as Parkinson's disease, multiple sclerosis, Alzheimer's, and damage caused to neurological systems as a result of stroke are also a main area of focus," states Pramod Goel, CEO and founder of PlacidWay, a leader in medical resources and providers based in Denver, Colorado. "Options with stem cell therapies include transplantation of mother cells, orthomolecular and hyperbaric medicine."

Stem cell therapies and methods for the treatment of Type 2 diabetes as well as preparation and rejuvenation of nervous system pathways as a result of trauma are also a major focus of stem cell Panama. Dr. Esteban Estrada is a specialist in cardiology and cardiovascular disease, and his studies and research are focused on regenerative medicine and in experimental phases of stem cell regenerative medicine and research, as well as research protocols based on quality clinical practices.

Panama provides travelers with beautiful destinations, accommodations, and entertainment venues, home to tropical rain forests, miles of Pacific and Caribbean coastline and beach activities, and numerous full-service resorts. Panama was chosen by the New York Times as the number one place to travel in 2012.

About PlacidWay

PlacidWay (placidway.com) is a leader in the medical tourism industry, dedicated to offering accurate, up-to-date information and resources regarding medical travel, international providers, treatments, procedures and destinations for international travelers.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PlacidWay

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


PlacidWay Furthers Relationship with Panama-Based Stem Cell Facility

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Pramod Goel - PlacidWay.com 
303-317-3607 info[.]placidway.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PlacidWay securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PlacidWay / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  S&A Capital Partner Ltd

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)